MAP Publication

Innovative Contracting | Cell & Gene Therapies

2020 |

Pharmaceutical companies and payers in the UK, US and Germany are increasingly signing Pay for Performance (P4P) contracts. Many of these contracts deal with cell and gene therapies. Post-launch evidence generation through registries is another topic of high interest. This first session of MAP’s “Meet the Experts” series discussed these areas, welcoming experts from the German landscape including: Dr. Barthold Dieters as a representative of GWQ who has signed several P4P contracts in the past; Dr. Alexander Natz, Secretary General, EUCOPE; and Dr. Peter Lütkes, a hospital controller who is familiar with hospital reimbursement for high priced medicines. The meeting was a great success, with fascinating insights and some thought provoking questions.


All Publications